Please upgrade your browser.
Roughly 2-3 percent of all people suffering from cancer have kidney cancer. The most common form of this disease is called clear cell renal cell carcinoma (ccRCC). In roughly half of all patients with this disease, the tumor develops metastases and generally cannot be cured.
Women who eat more tomatoes or other lycopene-containing fruits and vegetables may have a lower risk of developing kidney cancer, a study suggests.
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing CB-839 in Combination with Everolimus (CBE) vs. Placebo with Everolimus (PboE) in Patients with Advanced or Metastatic Renal Cell Carcinoma (RCC)
Xynomic Pharma, a clinical stage US oncology drug R&D company, today announced that it has entered into a strategic partnership with the University of California San Francisco ("UCSF") to conduct PAX Study, a multi-national, multi-center, randomized Phase 2/3 study of Pazopanib plus Abexinostat versus Pazopanib monotherapy in patients with locally advanced or metastatic renal cell carcinoma ("RCC").
“We have never seen anything like this in most human solid tumors,” Allegheny Health Network Oncologist Dr. Gene Finley said.
The companies are taking advantage of frightened cancer patients and their loved ones, said consumer safety officer Nicole Kornspan.
Researchers at the Mayo Clinic found surgery for patients with late-stage kidney cancer may more than double their life expectancy.
Being obese, with a body mass index ( BMI) of 30 or more, increases the risk of getting kidney cancer. It causes around 25% of cases in men and 22% in women.
Kidney Cancer Association (KCA) sponsors 12th annual medical meeting in Munich, Germany
A total of 462 patients were enrolled in the ADAPT study and randomized 2:1 between combination treatment with Rocapuldencel-T and sunitinib (combination arm) vs. sunitinib monotherapy (control arm).
|Powered by NeonCRM|